Concepedia

-174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis

Ivan Jančić, Nevena Arsenović-Ranin, Mirjana Šefik-Bukilica, S Zivojinović, Nemanja Damjanov, Vesna Spasovski, Sanja Srzentić Dražilov, Biljana Stanković, Sonja Pavlović

Rheumatology International · 2012 · 39 citations · 32 references

DOI

Concepts

References

32

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

Frank C. Arnett, Steven M. Edworthy, D. Blöch et al. · Arthritis & Rheumatism · 1988 · 19.9K citations

, , +12

Revised Criteria for the Classification of Rheumatoid Arthritis

Frank C. Arnett · Orthopaedic Nursing · 1990 · 7.7K citations

, , +7

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

, , +17

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Daniel Fishman, Gary Faulds, Rachel Jeffery et al. · Journal of Clinical Investigation · 1998 · 2.2K citations · Full text

, , +17

Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation

Anthony G. Wilson, Julian Symons, Tarra L. McDowell et al. · Proceedings of the National Academy of Sciences · 1997 · 2.2K citations

, , +14